User Acceptance Testing Uat Checklist

Standard Operating Procedure: User Acceptance Testing (UAT) Checklist

1. Document Control & Revision History

---

2. Executive Summary & Scope

2.1 Clinical Statement of Operational Boundaries

This Standard Operating Procedure (SOP) governs the execution, governance, validation, and sign-off phases of User Acceptance Testing (UAT) across all enterprise software deployments, mission-critical workflow migrations, and infrastructure modifications. UAT serves as the final operational gatekeeper prior to production promotion, certifying that the deployed system meets defined business requirements, functional specifications, and end-user operational readiness criteria.

2.2 Regulatory Standards & Compliance Framework

All UAT activities executed under this SOP must maintain absolute adherence to the following regulatory and institutional frameworks:

• ISO/IEC 27001: Information Security Management verification for data handling during testing phases.
• FDA 21 CFR Part 11: Electronic records and electronic signatures compliance where applicable to regulated industry platforms.
• SOC 2 Type II: Trust Services Criteria (Security, Availability, Processing Integrity) verification.
• GDPR & CCPA: Data privacy mandates ensuring no unmasked Production Personally Identifiable Information (PII) is utilized within non-production UAT environments.

---

3. Prerequisites & Tool Requirements

Prior to the formal initiation of any UAT cycle, the following prerequisites, access credentials, and technical tools must be provisioned and verified:

• Hardware & Equipment: Secure, enterprise-managed endpoint workstation running approved OS builds, utilizing encrypted multi-factor authentication (MFA) tokens.
• Software & Platform Access:
  • Dedicated UAT Environment access with synchronized production schema mappings.
  • Enterprise Test Management Suite (e.g., Jira/Xray, qTest, or Azure DevOps Test Plans).
  • Automated Defect Tracking and Incident Management System.
  • Enterprise Identity Provider (IdP) integration configured for Single Sign-On (SSO) and Role-Based Access Control (RBAC) validation.
• Data Provisioning: Sanitized, synthetic, or masked dataset mirroring production volume and complexity, loaded and verified via automated data-seeding scripts.
• Certifications & Credentials: Validated business stakeholder credentials, certified UAT Analyst clearance, and signed non-disclosure agreements (NDAs) where external consultants are engaged.

---

4. Roles & Responsibilities (RACI Matrix Table)

• R (Responsible): The role that performs the activity and executes the checklist tasks.
• A (Accountable): The single role with final approval authority and ultimate liability for the outcome.
• C (Consulted): The role providing advisory input, technical guidance, and domain expertise.
• I (Informed): The role kept updated on progress, milestones, and gate sign-offs.

---

5. Step-by-Step Operational Procedure

Phase 1: UAT Environment Provisioning & Readiness Verification

• 1.1 Verify that the UAT target environment infrastructure matches production-parity hardware and network topologies.
• 1.2 Confirm data masking protocols have executed successfully, ensuring zero unmasked PII exists in the UAT data store.
• 1.3 Validate integration endpoints, API gateways, and third-party sandbox connections are active and responding within acceptable latency thresholds ($\le 200\text{ms}$).
• 1.4 Execute baseline security vulnerability scans on the UAT build and clear all High/Critical CVE flags.

Phase 2: Test Case Generation & Traceability Mapping

• 2.1 Review business requirements documents (BRD) and functional specifications to establish complete test coverage.
• 2.2 Author end-to-end (E2E) test scripts within the Enterprise Test Management Suite, ensuring clear preconditions, execution steps, and expected results.
• 2.3 Map each test case to corresponding functional requirements to establish a verified Requirements Traceability Matrix (RTM).
• 2.4 Conduct a peer review of all authored test scenarios with the Business Process Owner (BPO) and sign off on test scope.

Phase 3: Test Execution & Defect Lifecycle Management

• 3.1 Conduct a formal UAT Kickoff Briefing with assigned business representatives and execution resources.
• 3.2 Execute test scripts sequentially according to the master testing schedule, recording actual results in real time.
• 3.3 Log any deviation between expected and actual results as a formal defect in the tracking system within 2 hours of discovery.
• 3.4 Classify defect severity (Critical, Major, Minor, Cosmetic) and assign routing to the designated Engineering Lead.
• 3.5 Retest and verify bug fixes upon deployment of hotfixes or patches to the UAT environment, updating test status from Failed to Passed.

Phase 4: Sign-Off, Go/No-Go Decision Gate & Production Promotion

• 4.1 Compile the final UAT Summary Report, including execution metrics, pass/fail ratios, and residual open defect logs.
• 4.2 Convene the Go/No-Go Decision Gate meeting with the Executive Steering Committee and BPO.
• 4.3 Obtain formal electronic signatures and institutional sign-off from the Accountable (A) Business Process Owner.
• 4.4 Archive all test artifacts, execution logs, and traceability matrices in the enterprise compliance repository for audit retention.

---

6. Quality Assurance & Verification Criteria

To achieve formal system acceptance, the following quantitative benchmarks and qualitative tolerances must be satisfied:

[Total Test Cases Executed] 
       │
       ├─► 100% Execution Rate Required
       │
       ├─► Pass Rate Target: ≥ 98% (Blockers/Critical must be 0)
       │
       └─► Open Defects: Zero (0) Critical/Major remaining

• Execution Completeness Threshold: 100% of planned test cases must be formally executed, blocked, or explicitly waived with documented BPO authorization.
• Pass Rate Benchmark: A minimum of 98% pass rate on initial execution; 100% pass rate achieved upon retesting.
• Defect Tolerance Limits:
  • Critical / Blockers: 0 permitted. Any active Critical defect halts the Go/No-Go gate immediately.
  • Major: 0 permitted unless an approved, risk-assessed workaround is documented and signed off by the BPO.
  • Minor / Cosmetic: $\le 5%$ of total test volume, permitted only if non-impactful to core business workflows.
• Audit Trail Verification: Immutable system logs must demonstrate complete traceability from business requirement to executed test script and final sign-off signature.

---

7. Practical Troubleshooting Scenarios

Scenario A: Environmental Data Corruption Mid-Execution

• Symptom: During Phase 3 execution, a batch data synchronization job corrupts the UAT database state, causing widespread test script failures and false-negative defect logging.
• Immediate Corrective Action Protocol:
  1. Halt all active UAT execution immediately by issuing a global testing freeze notification.
  2. Notify the UAT Lead and Infrastructure Operations Team within 15 minutes.
  3. Purge the corrupted UAT database schema and execute the automated data-seeding restoration script from the verified baseline golden backup.
  4. Perform data integrity checksum validation.
  5. Invalidate all test execution results logged during the corruption window, reset affected test cases to Not Run, and resume testing operations upon formal sign-off from the QA Engineer.

Scenario B: Unresolved Critical Defect Impeding Core Business Workflow

• Symptom: A Critical defect (e.g., payment gateway timeout) is discovered 48 hours prior to the scheduled Go-Live date, halting a primary revenue-generating business process.
• Immediate Corrective Action Protocol:
  1. Convene an emergency triage session with the Engineering Lead, BPO, and UAT Lead within 2 hours.
  2. Evaluate whether an emergency code patch can be deployed and re-tested within the strict pre-production window.
  3. If a patch is unviable, evaluate a documented operational workaround. If no viable workaround exists, invoke the No-Go protocol.
  4. Formally communicate schedule adjustment to the Executive Steering Committee, update the project master schedule, and defer production deployment until the defect is remediated and regression-tested.

Scenario C: Stakeholder Resource Unavailability / Bottleneck

• Symptom: Assigned business representatives fail to execute assigned test scripts within the allocated window, threatening project velocity and milestone delivery.
• Immediate Corrective Action Protocol:
  1. Identify bottlenecked modules and unexecuted test scripts via the Enterprise Test Management Suite dashboard.
  2. Escalate resource constraints to the Accountable Business Process Owner (BPO) within 24 hours of timeline deviation.
  3. Reallocate secondary pre-trained business analysts or certified proxy testers to assume execution responsibility, subject to BPO authorization.
  4. Log resource variance in the UAT Summary Report for post-project operational review and capacity planning adjustment.